These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18248671)

  • 61. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trastuzumab-Resistant Luminal B Breast Cancer Cells Show Basal-Like Cell Growth Features Through NF-κB-Activation.
    Kanzaki H; Mukhopadhya NK; Cui X; Ramanujan VK; Murali R
    Monoclon Antib Immunodiagn Immunother; 2016 Feb; 35(1):1-11. PubMed ID: 26871511
    [TBL] [Abstract][Full Text] [Related]  

  • 63. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.
    Bertucci F; Rypens C; Finetti P; Guille A; Adélaïde J; Monneur A; Carbuccia N; Garnier S; Dirix P; Gonçalves A; Vermeulen P; Debeb BG; Wang X; Dirix L; Ueno NT; Viens P; Cristofanilli M; Chaffanet M; Birnbaum D; Van Laere S
    Mol Oncol; 2020 Mar; 14(3):504-519. PubMed ID: 31854063
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy.
    Pavitra E; Kancharla J; Gupta VK; Prasad K; Sung JY; Kim J; Tej MB; Choi R; Lee JH; Han YK; Raju GSR; Bhaskar L; Huh YS
    Biomed Pharmacother; 2023 Jul; 163():114822. PubMed ID: 37146418
    [TBL] [Abstract][Full Text] [Related]  

  • 65. SLC35B2 expression is associated with a poor prognosis of invasive ductal breast carcinoma.
    Chim-ong A; Thawornkuno C; Chavalitshewinkoon-Petmitr P; Punyarit P; Petmitr S
    Asian Pac J Cancer Prev; 2014; 15(15):6065-70. PubMed ID: 25124574
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-κB/YY1 axis.
    Liu J; Zhan Y; Wang J; Wang J; Guo J; Kong D
    Mol Oncol; 2020 Dec; 14(12):3211-3233. PubMed ID: 33040438
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression.
    Abba MC; Drake JA; Hawkins KA; Hu Y; Sun H; Notcovich C; Gaddis S; Sahin A; Baggerly K; Aldaz CM
    Breast Cancer Res; 2004; 6(5):R499-513. PubMed ID: 15318932
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
    Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
    J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Effect of P-Glycoprotein (P-gp), Nuclear Factor-Kappa B (Nf-κb), and Aldehyde Dehydrogenase-1 (ALDH-1) Expression on Metastases, Recurrence and Survival in Advanced Breast Cancer Patients.
    Prajoko YW; Aryandono T
    Asian Pac J Cancer Prev; 2019 May; 20(5):1511-1518. PubMed ID: 31128056
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
    Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
    Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
    Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of genes for normalization of real-time RT-PCR data in breast carcinomas.
    Lyng MB; Laenkholm AV; Pallisgaard N; Ditzel HJ
    BMC Cancer; 2008 Jan; 8():20. PubMed ID: 18211679
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
    Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
    Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
    [TBL] [Abstract][Full Text] [Related]  

  • 76. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.
    Kleer CG; Zhang Y; Pan Q; Gallagher G; Wu M; Wu ZF; Merajver SD
    Breast Cancer Res; 2004; 6(1):R110-5. PubMed ID: 14696649
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Significance of Nuclear Factor-Kappa B (NF-κB) and Survivin in Breast Cancer and Their Association with Radiosensitivity and Prognosis.
    Cao Q; Ai XQ; Mushajiang M
    Breast Cancer (Dove Med Press); 2023; 15():175-188. PubMed ID: 36923396
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
    Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
    Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
    Sovak MA; Arsura M; Zanieski G; Kavanagh KT; Sonenshein GE
    Cell Growth Differ; 1999 Aug; 10(8):537-44. PubMed ID: 10470853
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic and therapeutic role of nuclear factor-kappa B (NF-kappaB) in breast cancer.
    Ahmed A
    J Ayub Med Coll Abbottabad; 2010; 22(3):218-21. PubMed ID: 22338460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.